Skip Nav Destination
Indolent and mantle cell NHL: the future is BRIGHT
Abnl(17p) in AML: who will guard the guardian?
Randomized trial of bendamustine-rituximab or R-CHOP/R-CVP in first-line treatment of indolent NHL or MCL: the BRIGHT study
Nordic MCL3 study: 90Y-ibritumomab-tiuxetan added to BEAM/C in non-CR patients before transplant in mantle cell lymphoma
Outcome of patients with abnl(17p) acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation
Issue Archive
May 8 2014
Table of Contents
INSIDE BLOOD COMMENTARIES
INSIDE BLOOD COMMENTARY
Indolent and mantle cell NHL: the future is BRIGHT
Clinical Trials & Observations
INSIDE BLOOD COMMENTARY
Abnl(17p) in AML: who will guard the guardian?
Clinical Trials & Observations
BLOOD WORK
PLENARY PAPER
Gene expression signatures delineate biological and prognostic subgroups in peripheral T-cell lymphoma
Javeed Iqbal,George Wright,Chao Wang,Andreas Rosenwald,Randy D. Gascoyne,Dennis D. Weisenburger,Timothy C. Greiner,Lynette Smith,Shuangping Guo,Ryan A. Wilcox,Bin Tean Teh,Soon Thye Lim,Soon Yong Tan,Lisa M. Rimsza,Elaine S. Jaffe,Elias Campo,Antonio Martinez,Jan Delabie,Rita M. Braziel,James R. Cook,Raymond R. Tubbs,German Ott,Eva Geissinger,Philippe Gaulard,Pier Paolo Piccaluga,Stefano A. Pileri,Wing Y. Au,Shigeo Nakamura,Masao Seto,Francoise Berger,Laurence de Leval,Joseph M. Connors,James Armitage,Julie Vose,Wing C. Chan,Louis M. Staudt,for the Lymphoma Leukemia Molecular Profiling Project and the International Peripheral T-cell Lymphoma Project,for the Lymphoma Leukemia Molecular Profiling Project and the International Peripheral T-cell Lymphoma Project,for the Lymphoma Leukemia Molecular Profiling Project and the International Peripheral T-cell Lymphoma Project,for the Lymphoma Leukemia Molecular Profiling Project and the International Peripheral T-cell Lymphoma Project,for the Lymphoma Leukemia Molecular Profiling Project and the International Peripheral T-cell Lymphoma Project,for the Lymphoma Leukemia Molecular Profiling Project and the International Peripheral T-cell Lymphoma Project,for the Lymphoma Leukemia Molecular Profiling Project and the International Peripheral T-cell Lymphoma Project,for the Lymphoma Leukemia Molecular Profiling Project and the International Peripheral T-cell Lymphoma Project,for the Lymphoma Leukemia Molecular Profiling Project and the International Peripheral T-cell Lymphoma Project,for the Lymphoma Leukemia Molecular Profiling Project and the International Peripheral T-cell Lymphoma Project,for the Lymphoma Leukemia Molecular Profiling Project and the International Peripheral T-cell Lymphoma Project,for the Lymphoma Leukemia Molecular Profiling Project and the International Peripheral T-cell Lymphoma Project,for the Lymphoma Leukemia Molecular Profiling Project and the International Peripheral T-cell Lymphoma Project,for the Lymphoma Leukemia Molecular Profiling Project and the International Peripheral T-cell Lymphoma Project,for the Lymphoma Leukemia Molecular Profiling Project and the International Peripheral T-cell Lymphoma Project,for the Lymphoma Leukemia Molecular Profiling Project and the International Peripheral T-cell Lymphoma Project,for the Lymphoma Leukemia Molecular Profiling Project and the International Peripheral T-cell Lymphoma Project,for the Lymphoma Leukemia Molecular Profiling Project and the International Peripheral T-cell Lymphoma Project,for the Lymphoma Leukemia Molecular Profiling Project and the International Peripheral T-cell Lymphoma Project,for the Lymphoma Leukemia Molecular Profiling Project and the International Peripheral T-cell Lymphoma Project,for the Lymphoma Leukemia Molecular Profiling Project and the International Peripheral T-cell Lymphoma Project,for the Lymphoma Leukemia Molecular Profiling Project and the International Peripheral T-cell Lymphoma Project,for the Lymphoma Leukemia Molecular Profiling Project and the International Peripheral T-cell Lymphoma Project,for the Lymphoma Leukemia Molecular Profiling Project and the International Peripheral T-cell Lymphoma Project,for the Lymphoma Leukemia Molecular Profiling Project and the International Peripheral T-cell Lymphoma Project,for the Lymphoma Leukemia Molecular Profiling Project and the International Peripheral T-cell Lymphoma Project,for the Lymphoma Leukemia Molecular Profiling Project and the International Peripheral T-cell Lymphoma Project,for the Lymphoma Leukemia Molecular Profiling Project and the International Peripheral T-cell Lymphoma Project,for the Lymphoma Leukemia Molecular Profiling Project and the International Peripheral T-cell Lymphoma Project,for the Lymphoma Leukemia Molecular Profiling Project and the International Peripheral T-cell Lymphoma Project,for the Lymphoma Leukemia Molecular Profiling Project and the International Peripheral T-cell Lymphoma Project,for the Lymphoma Leukemia Molecular Profiling Project and the International Peripheral T-cell Lymphoma Project,for the Lymphoma Leukemia Molecular Profiling Project and the International Peripheral T-cell Lymphoma Project,for the Lymphoma Leukemia Molecular Profiling Project and the International Peripheral T-cell Lymphoma Project,for the Lymphoma Leukemia Molecular Profiling Project and the International Peripheral T-cell Lymphoma Project,for the Lymphoma Leukemia Molecular Profiling Project and the International Peripheral T-cell Lymphoma Project
REVIEW ARTICLE
CLINICAL TRIALS AND OBSERVATIONS
Randomized trial of bendamustine-rituximab or R-CHOP/R-CVP in first-line treatment of indolent NHL or MCL: the BRIGHT study
Clinical Trials & Observations
Ian W. Flinn,Richard van der Jagt,Brad S. Kahl,Peter Wood,Tim E. Hawkins,David MacDonald,Mark Hertzberg,Yiu-Lam Kwan,David Simpson,Michael Craig,Kathryn Kolibaba,Samar Issa,Regina Clementi,Doreen M. Hallman,Mihaela Munteanu,Ling Chen,John M. Burke
Nordic MCL3 study: 90Y-ibritumomab-tiuxetan added to BEAM/C in non-CR patients before transplant in mantle cell lymphoma
Clinical Trials & Observations
Arne Kolstad,Anna Laurell,Mats Jerkeman,Kirsten Grønbæk,Erkki Elonen,Riikka Räty,Lone Bredo Pedersen,Annika Loft,Trond Velde Bogsrud,Eva Kimby,Per Boye Hansen,Unn-Merete Fagerli,Herman Nilsson-Ehle,Grete Fossum Lauritzsen,Anne Kristine Lehmann,Christer Sundstrom,Marja-Liisa Karjalainen-Lindsberg,Elisabeth Ralfkiaer,Mats Ehinger,Jan Delabie,Hans Bentzen,Jukka Schildt,Kamelia Kostova-Aherdan,Henrik Frederiksen,Peter de Nully Brown,Christian H. Geisler,on behalf of the Nordic Lymphoma Group,on behalf of the Nordic Lymphoma Group,on behalf of the Nordic Lymphoma Group,on behalf of the Nordic Lymphoma Group,on behalf of the Nordic Lymphoma Group,on behalf of the Nordic Lymphoma Group,on behalf of the Nordic Lymphoma Group,on behalf of the Nordic Lymphoma Group,on behalf of the Nordic Lymphoma Group,on behalf of the Nordic Lymphoma Group,on behalf of the Nordic Lymphoma Group,on behalf of the Nordic Lymphoma Group,on behalf of the Nordic Lymphoma Group,on behalf of the Nordic Lymphoma Group,on behalf of the Nordic Lymphoma Group,on behalf of the Nordic Lymphoma Group,on behalf of the Nordic Lymphoma Group,on behalf of the Nordic Lymphoma Group,on behalf of the Nordic Lymphoma Group,on behalf of the Nordic Lymphoma Group,on behalf of the Nordic Lymphoma Group,on behalf of the Nordic Lymphoma Group,on behalf of the Nordic Lymphoma Group,on behalf of the Nordic Lymphoma Group,on behalf of the Nordic Lymphoma Group,on behalf of the Nordic Lymphoma Group
Outcome of patients with abnl(17p) acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation
Clinical Trials & Observations
Jan M. Middeke,Min Fang,Jan J. Cornelissen,Brigitte Mohr,Frederick R. Appelbaum,Michael Stadler,Jaime Sanz,Herrad Baurmann,Gesine Bug,Kerstin Schäfer-Eckart,Ute Hegenbart,Tilmann Bochtler,Christoph Röllig,Friedrich Stölzel,Roland B. Walter,Gerhard Ehninger,Martin Bornhäuser,Bob Löwenberg,Johannes Schetelig
HEMATOPOIESIS AND STEM CELLS
IMMUNOBIOLOGY
A mouse model of HIES reveals pro- and anti-inflammatory functions of STAT3
Scott M. Steward-Tharp,Arian Laurence,Yuka Kanno,Alex Kotlyar,Alejandro V. Villarino,Giuseppe Sciume,Stefan Kuchen,Wolfgang Resch,Elizabeth A. Wohlfert,Kan Jiang,Kiyoshi Hirahara,Golnaz Vahedi,Hong-wei Sun,Lionel Feigenbaum,Joshua D. Milner,Steven M. Holland,Rafael Casellas,Fiona Powrie,John J. O'Shea
LYMPHOID NEOPLASIA
The genomic landscape of mantle cell lymphoma is related to the epigenetically determined chromatin state of normal B cells
Jenny Zhang,Dereje Jima,Andrea B. Moffitt,Qingquan Liu,Magdalena Czader,Eric D. Hsi,Yuri Fedoriw,Cherie H. Dunphy,Kristy L. Richards,Javed I. Gill,Zhen Sun,Cassandra Love,Paula Scotland,Eric Lock,Shawn Levy,David S. Hsu,David Dunson,Sandeep S. Dave
GATA-3 expression identifies a high-risk subset of PTCL, NOS with distinct molecular and clinical features
Tianjiao Wang,Andrew L. Feldman,David A. Wada,Ye Lu,Avery Polk,Robert Briski,Kay Ristow,Thomas M. Habermann,Dafydd Thomas,Steven C. Ziesmer,Linda E. Wellik,Thomas M. Lanigan,Thomas E. Witzig,Mark R. Pittelkow,Nathanael G. Bailey,Alexandra C. Hristov,Megan S. Lim,Stephen M. Ansell,Ryan A. Wilcox
MYELOID NEOPLASIA
CD16xCD33 bispecific killer cell engager (BiKE) activates NK cells against primary MDS and MDSC CD33+ targets
Michelle K. Gleason,Julie A. Ross,Erica D. Warlick,Troy C. Lund,Michael R. Verneris,Andres Wiernik,Stephen Spellman,Michael D. Haagenson,Alexander J. Lenvik,Mark R. Litzow,Pearlie K. Epling-Burnette,Bruce R. Blazar,Louis M. Weiner,Daniel J. Weisdorf,Daniel A. Vallera,Jeffrey S. Miller
PHAGOCYTES, GRANULOCYTES, AND MYELOPOIESIS
PLATELETS AND THROMBOPOIESIS
Adherence to the Mediterranean diet is associated with lower platelet and leukocyte counts: results from the Moli-sani study
Marialaura Bonaccio,Augusto Di Castelnuovo,Amalia De Curtis,Simona Costanzo,Mariarosaria Persichillo,Maria Benedetta Donati,Chiara Cerletti,Licia Iacoviello,Giovanni de Gaetano,on behalf of the Moli-sani Project Investigators,on behalf of the Moli-sani Project Investigators,on behalf of the Moli-sani Project Investigators,on behalf of the Moli-sani Project Investigators,on behalf of the Moli-sani Project Investigators,on behalf of the Moli-sani Project Investigators,on behalf of the Moli-sani Project Investigators,on behalf of the Moli-sani Project Investigators,on behalf of the Moli-sani Project Investigators
TRANSPLANTATION
ERRATA
-
Cover Image
Cover Image
![issue cover]()
Abundant alternatively polarized macrophages, demonstrated here by double immunofluorescent staining for the macrophage markers CD163 (green) and phosphorylated STAT3 (red), are observed in peripheral T-cell lymphoma, not otherwise specified. (DAPI, a nuclear stain, blue). See the article by Wang et al on page 3007.
- PDF Icon PDF LinkFront Matter
- PDF Icon PDF LinkTable of Contents
- PDF Icon PDF LinkBack Matter
- PDF Icon PDF LinkAdvertising
- PDF Icon PDF LinkEditorial Board
Advertisement intended for health care professionals
Email alerts
Advertisement intended for health care professionals
